MedPath

To study about the effect of giving a protein called albumin in patients with inner abdominal wall inflammatio

Phase 2
Conditions
Health Condition 1: K650- Generalized (acute) peritonitis
Registration Number
CTRI/2023/11/059801
Lead Sponsor
All India Institute of Medical Sciences, New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Written informed consent

2. Within 24 hours of diagnosis of secondary peritonitis

3. Serum albumin level less than 3 g/dl

Exclusion Criteria

1. History of allergy to albumin

2. Pregnant women

3. Presence of volume overload [ as assessed by the

physician]

4.Conditions in which albumin is clinically

indicated –

Nephrotic syndrome

Burns

Intestinal malabsorption syndrome

Severe liver cirrhosis [ Child Pugh score – C]

Congestive heart failure [ NYHA class of 3

or 4 ]

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath